Combining IMWG GA and hematopoietic score to optimize the evaluation of dynamic chemotherapy tolerance in multiple myeloma
Hemo-IMWG GA offers a dynamic, integrated approach for evaluating chemotherapy tolerance in MM. By combining functional and hematopoietic dimensions, it improves prediction of treatment-related toxicity-especially hematological AEs-and aids personalized treatment decisions.
Authors
- Yadong Chen (ORCID: https://orcid.org/0000-0002-2189-9356)
- Huihua An
- Fenfen He
- Yanyu Chen (ORCID: https://orcid.org/0000-0002-2275-6912)
- Dongxia Wu (ORCID: https://orcid.org/0000-0002-1410-2740)
- Yongjiang Zheng (ORCID: https://orcid.org/0000-0003-0200-9749)
- Zhibin He (ORCID: https://orcid.org/0000-0001-8235-300X)
- Qian Liu (ORCID: https://orcid.org/0000-0002-2788-6222)
Institutions
- Sun Yat-sen University (CN)
- Southern Command Hospital (IN)
- Third Affiliated Hospital of Sun Yat-sen University (CN)
- Command Hospital Air Force (IN)
Publication Details
- Journal
- Annals of Medicine
- Published
- 2025-10-14
- DOI
- https://doi.org/10.1080/07853890.2025.2558127
- Citations
- 1
- Primary Topic
- Multiple Myeloma Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.77